Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 54

1.

Validity of the Polar V800 monitor for measuring heart rate variability in mountain running route conditions.

Caminal P, Sola F, Gomis P, Guasch E, Perera A, Soriano N, Mont L.

Eur J Appl Physiol. 2018 Mar;118(3):669-677. doi: 10.1007/s00421-018-3808-0. Epub 2018 Jan 22.

2.

Feeding behavior and social interactions of the Argentine ant Linepithema humile change with sucrose concentration.

Sola FJ, Josens R.

Bull Entomol Res. 2016 Aug;106(4):522-9. doi: 10.1017/S0007485316000201. Epub 2016 Apr 11.

PMID:
27063551
3.

Discovery of 2-[1-(4,4-Difluorocyclohexyl)piperidin-4-yl]-6-fluoro-3-oxo-2,3-dihydro-1H-isoindole-4-carboxamide (NMS-P118): A Potent, Orally Available, and Highly Selective PARP-1 Inhibitor for Cancer Therapy.

Papeo G, Posteri H, Borghi D, Busel AA, Caprera F, Casale E, Ciomei M, Cirla A, Corti E, D'Anello M, Fasolini M, Forte B, Galvani A, Isacchi A, Khvat A, Krasavin MY, Lupi R, Orsini P, Perego R, Pesenti E, Pezzetta D, Rainoldi S, Riccardi-Sirtori F, Scolaro A, Sola F, Zuccotto F, Felder ER, Donati D, Montagnoli A.

J Med Chem. 2015 Sep 10;58(17):6875-98. doi: 10.1021/acs.jmedchem.5b00680. Epub 2015 Aug 26.

PMID:
26222319
4.

Synthesis and biological evaluation of RGD peptidomimetic-paclitaxel conjugates bearing lysosomally cleavable linkers.

Dal Corso A, Caruso M, Belvisi L, Arosio D, Piarulli U, Albanese C, Gasparri F, Marsiglio A, Sola F, Troiani S, Valsasina B, Pignataro L, Donati D, Gennari C.

Chemistry. 2015 Apr 27;21(18):6921-9. doi: 10.1002/chem.201500158. Epub 2015 Mar 17.

PMID:
25784522
5.

Fragment-based hit discovery and structure-based optimization of aminotriazoloquinazolines as novel Hsp90 inhibitors.

Casale E, Amboldi N, Brasca MG, Caronni D, Colombo N, Dalvit C, Felder ER, Fogliatto G, Galvani A, Isacchi A, Polucci P, Riceputi L, Sola F, Visco C, Zuccotto F, Casuscelli F.

Bioorg Med Chem. 2014 Aug 1;22(15):4135-50. doi: 10.1016/j.bmc.2014.05.056. Epub 2014 Jun 14.

PMID:
24980703
6.

Knowing the enemy: ant behavior and control in a pediatric hospital of Buenos Aires.

Josens R, Sola FJ, Marchisio N, Di Renzo MA, Giacometti A.

Springerplus. 2014 May 6;3:229. doi: 10.1186/2193-1801-3-229. eCollection 2014.

7.

Increased tensile strength of carbon nanotube yarns and sheets through chemical modification and electron beam irradiation.

Miller SG, Williams TS, Baker JS, Solá F, Lebron-Colon M, McCorkle LS, Wilmoth NG, Gaier J, Chen M, Meador MA.

ACS Appl Mater Interfaces. 2014 May 14;6(9):6120-6. doi: 10.1021/am4058277. Epub 2014 Apr 10.

PMID:
24720450
8.

Discovery of NMS-E973 as novel, selective and potent inhibitor of heat shock protein 90 (Hsp90).

Brasca MG, Mantegani S, Amboldi N, Bindi S, Caronni D, Casale E, Ceccarelli W, Colombo N, De Ponti A, Donati D, Ermoli A, Fachin G, Felder ER, Ferguson RD, Fiorelli C, Guanci M, Isacchi A, Pesenti E, Polucci P, Riceputi L, Sola F, Visco C, Zuccotto F, Fogliatto G.

Bioorg Med Chem. 2013 Nov 15;21(22):7047-63. doi: 10.1016/j.bmc.2013.09.018. Epub 2013 Sep 19. Erratum in: Bioorg Med Chem. 2014 Jan 1;22(1):662.

PMID:
24100158
9.
10.

NMS-E973, a novel synthetic inhibitor of Hsp90 with activity against multiple models of drug resistance to targeted agents, including intracranial metastases.

Fogliatto G, Gianellini L, Brasca MG, Casale E, Ballinari D, Ciomei M, Degrassi A, De Ponti A, Germani M, Guanci M, Paolucci M, Polucci P, Russo M, Sola F, Valsasina B, Visco C, Zuccotto F, Donati D, Felder E, Pesenti E, Galvani A, Mantegani S, Isacchi A.

Clin Cancer Res. 2013 Jul 1;19(13):3520-32. doi: 10.1158/1078-0432.CCR-12-3512. Epub 2013 May 14.

11.

A novel methane sensor based on porous SnO2 nanorods: room temperature to high temperature detection.

Biaggi-Labiosa A, Solá F, Lebrón-Colón M, Evans LJ, Xu JC, Hunter G, Berger GM, González JM.

Nanotechnology. 2012 Nov 16;23(45):455501. doi: 10.1088/0957-4484/23/45/455501. Epub 2012 Oct 12.

PMID:
23064120
12.

NMS-P937, an orally available, specific small-molecule polo-like kinase 1 inhibitor with antitumor activity in solid and hematologic malignancies.

Valsasina B, Beria I, Alli C, Alzani R, Avanzi N, Ballinari D, Cappella P, Caruso M, Casolaro A, Ciavolella A, Cucchi U, De Ponti A, Felder E, Fiorentini F, Galvani A, Gianellini LM, Giorgini ML, Isacchi A, Lansen J, Pesenti E, Rizzi S, Rocchetti M, Sola F, Moll J.

Mol Cancer Ther. 2012 Apr;11(4):1006-16. doi: 10.1158/1535-7163.MCT-11-0765. Epub 2012 Feb 7.

13.

Surface oxidation study of single wall carbon nanotubes.

Lebrón-Colón M, Meador MA, Lukco D, Solá F, Santos-Pérez J, McCorkle LS.

Nanotechnology. 2011 Nov 11;22(45):455707. doi: 10.1088/0957-4484/22/45/455707. Epub 2011 Oct 21.

PMID:
22020272
14.

A new scanning electron microscopy approach to image aerogels at the nanoscale.

Solá F, Hurwitz F, Yang J.

Nanotechnology. 2011 Apr 29;22(17):175704. doi: 10.1088/0957-4484/22/17/175704. Epub 2011 Mar 16.

PMID:
21411927
15.

Phosphorylation of TCTP as a marker for polo-like kinase-1 activity in vivo.

Cucchi U, Gianellini LM, De Ponti A, Sola F, Alzani R, Patton V, Pezzoni A, Troiani S, Saccardo MB, Rizzi S, Giorgini ML, Cappella P, Beria I, Valsasina B.

Anticancer Res. 2010 Dec;30(12):4973-85.

PMID:
21187478
16.

Targeting the mitotic checkpoint for cancer therapy with NMS-P715, an inhibitor of MPS1 kinase.

Colombo R, Caldarelli M, Mennecozzi M, Giorgini ML, Sola F, Cappella P, Perrera C, Depaolini SR, Rusconi L, Cucchi U, Avanzi N, Bertrand JA, Bossi RT, Pesenti E, Galvani A, Isacchi A, Colotta F, Donati D, Moll J.

Cancer Res. 2010 Dec 15;70(24):10255-64. doi: 10.1158/0008-5472.CAN-10-2101.

17.

4,5-Dihydro-1H-pyrazolo[4,3-h]quinazolines as potent and selective Polo-like kinase 1 (PLK1) inhibitors.

Beria I, Valsasina B, Brasca MG, Ceccarelli W, Colombo M, Cribioli S, Fachin G, Ferguson RD, Fiorentini F, Gianellini LM, Giorgini ML, Moll JK, Posteri H, Pezzetta D, Roletto F, Sola F, Tesei D, Caruso M.

Bioorg Med Chem Lett. 2010 Nov 15;20(22):6489-94. doi: 10.1016/j.bmcl.2010.09.060. Epub 2010 Sep 17.

PMID:
20932759
18.

Reinforced thermoplastic polyimide with dispersed functionalized single wall carbon nanotubes.

Lebrón-Colón M, Meador MA, Gaier JR, Solá F, Scheiman DA, McCorkle LS.

ACS Appl Mater Interfaces. 2010 Mar;2(3):669-76. doi: 10.1021/am900682s.

PMID:
20356267
19.

Cell division cycle 7 kinase inhibitors: 1H-pyrrolo[2,3-b]pyridines, synthesis and structure-activity relationships.

Ermoli A, Bargiotti A, Brasca MG, Ciavolella A, Colombo N, Fachin G, Isacchi A, Menichincheri M, Molinari A, Montagnoli A, Pillan A, Rainoldi S, Sirtori FR, Sola F, Thieffine S, Tibolla M, Valsasina B, Volpi D, Santocanale C, Vanotti E.

J Med Chem. 2009 Jul 23;52(14):4380-90. doi: 10.1021/jm900248g.

PMID:
19555113
20.

Field Emission and Radial Distribution Function Studies of Fractal-like Amorphous Carbon Nanotips.

Solá F, Biaggi-Labiosa A, Fonseca LF, Resto O, Lebrón-Colón M, Meador MA.

Nanoscale Res Lett. 2009 Feb 13;4(5):431-436.

21.

High-content analysis of kinase activity in cells.

Gasparri F, Sola F, Bandiera T, Moll J, Galvani A.

Comb Chem High Throughput Screen. 2008 Aug;11(7):523-36. Review.

PMID:
18694389
22.

Nanocrystalline silicon as the light emitting material of a field emission display device.

Biaggi-Labiosa A, Solá F, Resto O, Fonseca LF, González-Berríos A, De Jesús J, Morell G.

Nanotechnology. 2008 Jun 4;19(22):225202. doi: 10.1088/0957-4484/19/22/225202. Epub 2008 Apr 25.

PMID:
21825754
23.

A Cdc7 kinase inhibitor restricts initiation of DNA replication and has antitumor activity.

Montagnoli A, Valsasina B, Croci V, Menichincheri M, Rainoldi S, Marchesi V, Tibolla M, Tenca P, Brotherton D, Albanese C, Patton V, Alzani R, Ciavolella A, Sola F, Molinari A, Volpi D, Avanzi N, Fiorentini F, Cattoni M, Healy S, Ballinari D, Pesenti E, Isacchi A, Moll J, Bensimon A, Vanotti E, Santocanale C.

Nat Chem Biol. 2008 Jun;4(6):357-65. doi: 10.1038/nchembio.90. Epub 2008 May 11.

PMID:
18469809
24.

Growth and characterization of branched carbon nanostructures arrays in nano-patterned surfaces from porous silicon substrates.

Solá F, Resto O, Biaggi-Labiosa A, Fonseca LF.

Micron. 2009 Jan;40(1):80-4. doi: 10.1016/j.micron.2008.01.005. Epub 2008 Jan 17.

PMID:
18296056
25.

Loss of huntingtin function complemented by small molecules acting as repressor element 1/neuron restrictive silencer element silencer modulators.

Rigamonti D, Bolognini D, Mutti C, Zuccato C, Tartari M, Sola F, Valenza M, Kazantsev AG, Cattaneo E.

J Biol Chem. 2007 Aug 24;282(34):24554-62. Epub 2007 Jun 12.

26.

PHA-680632, a novel Aurora kinase inhibitor with potent antitumoral activity.

Soncini C, Carpinelli P, Gianellini L, Fancelli D, Vianello P, Rusconi L, Storici P, Zugnoni P, Pesenti E, Croci V, Ceruti R, Giorgini ML, Cappella P, Ballinari D, Sola F, Varasi M, Bravo R, Moll J.

Clin Cancer Res. 2006 Jul 1;12(13):4080-9.

27.

Quantification of the proliferation index of human dermal fibroblast cultures with the ArrayScan high-content screening reader.

Gasparri F, Mariani M, Sola F, Galvani A.

Drug Discov Today. 2005 Autumn;Suppl:31-42.

PMID:
23570164
28.

Cdc7 inhibition reveals a p53-dependent replication checkpoint that is defective in cancer cells.

Montagnoli A, Tenca P, Sola F, Carpani D, Brotherton D, Albanese C, Santocanale C.

Cancer Res. 2004 Oct 1;64(19):7110-6.

29.
30.
31.

Characterization of superoxide dismutases in anoxia- and hyperoxia-tolerant symbiotic cnidarians.

Richier S, Merle PL, Furla P, Pigozzi D, Sola F, Allemand D.

Biochim Biophys Acta. 2003 Apr 7;1621(1):84-91.

PMID:
12667614
32.

Essential role of human CDT1 in DNA replication and chromatin licensing.

Rialland M, Sola F, Santocanale C.

J Cell Sci. 2002 Apr 1;115(Pt 7):1435-40.

33.

In vivo antitumor activity and host toxicity of methoxymorpholinyl doxorubicin: role of cytochrome P450 3A.

Quintieri L, Rosato A, Napoli E, Sola F, Geroni C, Floreani M, Zanovello P.

Cancer Res. 2000 Jun 15;60(12):3232-8.

34.

Antiangiogenic, antitumoural and antimetastatic effects of two distamycin A derivatives with anti-HIV-1 Tat activity in a Kaposi's sarcoma-like murine model.

Possati L, Campioni D, Sola F, Leone L, Ferrante L, Trabanelli C, Ciomei M, Montesi M, Rocchetti R, Talevi S, Bompadre S, Caputo A, Barbanti-Brodano G, Corallini A.

Clin Exp Metastasis. 1999;17(7):575-82.

PMID:
10845556
35.

Toxicity of fatty acid 18:5n3 from Gymnodinium cf. mikimotoi: I. Morphological and biochemical aspects on Dicentrarchus labrax gills and intestine.

Sola F, Masoni A, Fossat B, Porthé-Nibelle J, Gentien P, Bodennec G.

J Appl Toxicol. 1999 Jul-Aug;19(4):279-84.

PMID:
10439343
36.

Toxicity of fatty acid 18:5n3 from Gymnodinium cf. mikimotoi: II. Intracellular pH and K+ uptake in isolated trout hepatocytes.

Fossat B, Porthé-Nibelle J, Sola F, Masoni A, Gentien P, Bodennec G.

J Appl Toxicol. 1999 Jul-Aug;19(4):275-8.

PMID:
10439342
37.

[Pseudo-Bartter syndrome induced by uncontrollable vomiting].

Sola F, André JL.

Arch Pediatr. 1999 Apr;6(4):481-3. French. No abstract available.

PMID:
10230496
38.

The antitumor efficacy of cytotoxic drugs is potentiated by treatment with PNU 145156E, a growth-factor-complexing molecule.

Sola F, Capolongo L, Moneta D, Ubezio P, Grandi M.

Cancer Chemother Pharmacol. 1999;43(3):241-6.

PMID:
9923555
39.

Characterization of the effects of two polysulfonated distamycin A derivatives, PNU145156E and PNU153429, on HIV type 1 Tat protein.

Corallini A, Betti M, Rusnati M, Campioni D, Ciomei M, Sola F, Calza N, Zauli G, Presta M, Barbanti-Brodano G, Caputo A.

AIDS Res Hum Retroviruses. 1998 Nov 20;14(17):1561-71.

PMID:
9840289
40.

Endothelial cells overexpressing basic fibroblast growth factor (FGF-2) induce vascular tumors in immunodeficient mice.

Sola F, Gualandris A, Belleri M, Giuliani R, Coltrini D, Bastaki M, Tosatti MP, Bonardi F, Vecchi A, Fioretti F, Ciomei M, Grandi M, Mantovani A, Presta M.

Angiogenesis. 1997;1(1):102-116.

PMID:
14517397
41.

Effects of copper on gill structure and transport function in the rainbow trout, Oncorhynchus mykiss.

Sola F, Isaia J, Masoni A.

J Appl Toxicol. 1995 Sep-Oct;15(5):391-8.

PMID:
8666723
42.

FCE 27266, a sulfonic distamycin derivative, inhibits experimental and spontaneous lung and liver metastasis.

Sola F, Farao M, Ciomei M, Pastori A, Mongelli N, Grandi M.

Invasion Metastasis. 1995;15(5-6):222-31.

PMID:
8765197
43.

Antitumor activity of FCE 26644 a new growth-factor complexing molecule.

Sola F, Farao M, Pesenti E, Marsiglio A, Mongelli N, Grandi M.

Cancer Chemother Pharmacol. 1995;36(3):217-22.

PMID:
7781141
44.

Effects of lead loads on branchial osmoregulatory mechanisms in the rainbow trout Oncorhynchus mykiss.

Sola F, Masoni A, Isaia J.

J Appl Toxicol. 1994 Sep-Oct;14(5):343-9.

PMID:
7822683
45.

New sulfonated distamycin A derivatives with bFGF complexing activity.

Ciomei M, Pastori W, Mariani M, Sola F, Grandi M, Mongelli N.

Biochem Pharmacol. 1994 Jan 20;47(2):295-302.

PMID:
7508230
46.

Inhibition of lung and liver tumor colonies in mice pretreated with suramin.

Sola F, Farao M, Marsiglio A, Mariani M, Grandi M.

Invasion Metastasis. 1993;13(3):163-8.

PMID:
8112976
47.

Suramin prevents neovascularisation and tumour growth through blocking of basic fibroblast growth factor activity.

Pesenti E, Sola F, Mongelli N, Grandi M, Spreafico F.

Br J Cancer. 1992 Aug;66(2):367-72.

48.

In vivo activity of novel sulphonic derivatives of distamycin A.

Sola F, Biasoli G, Pesenti E, Farao M, Della Torre P, Mongelli N, Grandi M.

EXS. 1992;61:459-62.

PMID:
1377572
49.
50.

Supplemental Content

Support Center